Last 48 quarters of trend data
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 4.34 | 2.54 | — | 21.36 | 44.17 | — | — | — | — | — | — | — | — | 7.17 | — | 38.06 | — | 8.01 | 11.93 | 5.03 | 17.37 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | -10.5% | — | +656.1% | — | -53.7% | -54.9% | -73.5% | -36.2% | |
| P/S Ratio | 1.05 | 2.07 | 2.66 | 2.74 | 2.78 | 3.21 | 2.69 | 4.05 | 2.52 | 3.89 | 2.43 | 2.60 | — | 2.66 | 3.96 | 3.40 | 4.30 | 4.88 | 5.51 | 7.59 | 8.47 |
| — | -35.6% | -1.1% | -32.2% | +10.3% | -17.5% | +11.0% | +55.6% | — | +46.1% | -38.8% | -23.5% | — | -45.5% | -28.1% | -55.2% | -49.3% | -35.1% | -27.6% | -8.7% | -2.1% | |
| P/B Ratio | 0.24 | 0.45 | 0.61 | 0.61 | 0.65 | 0.65 | 0.54 | 0.76 | 0.49 | 0.65 | 0.42 | 0.42 | 0.39 | 0.39 | 0.67 | 0.58 | 0.78 | 0.80 | 1.03 | 1.42 | 1.67 |
| — | -31.6% | +14.6% | -19.9% | +32.9% | +1.3% | +28.3% | +80.7% | +27.4% | +63.9% | -37.3% | -27.8% | -50.3% | -51.1% | -35.4% | -59.0% | -53.6% | -43.9% | -28.4% | -6.2% | +4.5% | |
| P/FCF | 5.19 | — | 11.06 | — | 4.69 | 41.01 | 12.51 | 2357.80 | 7.73 | 14.83 | 18.34 | 9.49 | 5.43 | 5.16 | 18.10 | 9.06 | 9.20 | 8.31 | 13.89 | 17.65 | 15.05 |
| — | — | -11.6% | — | -39.3% | +176.5% | -31.8% | +24750.3% | +42.4% | +187.7% | +1.3% | +4.7% | -41.0% | -37.9% | +30.3% | -48.6% | -38.9% | -41.2% | -17.2% | +8.4% | -50.4% | |
| EV / EBITDA | 12.17 | 14.43 | 14.15 | 14.17 | 12.87 | 16.06 | 14.50 | 17.87 | 10.46 | 16.94 | 12.78 | 13.69 | — | 10.40 | 5.88 | 9.40 | 9.95 | 10.11 | 10.75 | 12.36 | 13.66 |
| — | -10.1% | -2.4% | -20.7% | +23.0% | -5.2% | +13.5% | +30.5% | — | +62.8% | +117.4% | +45.6% | — | +2.9% | -45.3% | -23.9% | -27.2% | -19.5% | -15.7% | -6.6% | +1.2% | |
| EV / EBIT | 19.20 | 7.34 | 20.86 | 22.65 | 7.22 | 47.16 | 71.65 | 434.89 | 20.86 | — | — | — | — | 13.99 | — | 16.44 | 16.42 | 17.22 | 17.57 | 19.99 | 21.88 |
| — | -84.4% | -70.9% | -94.8% | -65.4% | — | — | — | — | — | — | — | — | -18.8% | — | -17.7% | -24.9% | -16.6% | -13.8% | -6.2% | -1.8% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 96.3% | 95.4% | 42.1% | 96.1% | 96.5% | 96.2% | 95.5% | 96.9% | 95.8% | 97.8% | 97.1% | 98.2% | 102.7% | 97.9% | 92.9% | 98.0% | 98.0% | 97.7% | 94.9% | 97.9% | 98.1% |
| — | -0.8% | -55.9% | -0.8% | +0.7% | -1.6% | -1.7% | -1.4% | -6.7% | -0.1% | +4.5% | +0.2% | +4.8% | +0.2% | -2.1% | +0.1% | -0.1% | -0.5% | -0.3% | -0.6% | -0.2% | |
| Operating Margin | 55.5% | 46.2% | 55.5% | 55.6% | 62.6% | 52.1% | 56.8% | 49.3% | 83.7% | -9.2% | 45.5% | 58.1% | 190.5% | — | 82.8% | 86.5% | 87.0% | 87.5% | 85.5% | 88.0% | 88.9% |
| — | -11.4% | -2.4% | +12.9% | -25.3% | +669.5% | +24.8% | -15.1% | -56.0% | — | -45.0% | -32.9% | +119.1% | — | -3.3% | -1.7% | -2.2% | -1.7% | -0.9% | -0.9% | +0.9% | |
| Net Margin | -28.5% | 80.6% | -1.0% | 13.0% | 6.4% | -32.7% | -40.9% | -52.8% | -175.5% | -354.8% | -120.3% | -322.7% | 542.5% | 38.1% | -12.0% | 9.1% | -36.2% | 61.0% | 45.7% | 151.4% | 49.6% |
| — | +346.3% | +97.6% | +124.6% | +103.6% | +90.8% | +66.0% | +83.6% | -132.3% | -1031.9% | -900.4% | -3658.2% | +1597.2% | -37.6% | -126.3% | -94.0% | -173.0% | +41.8% | +55.2% | +242.0% | +53.1% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -5.9% | 4.4% | -0.1% | 0.7% | 0.4% | -1.6% | -2.1% | -2.5% | -8.0% | -13.8% | -5.2% | -12.2% | -8.3% | 1.4% | -0.5% | 0.4% | -1.6% | 2.5% | 2.1% | 7.3% | 2.5% |
| — | +369.9% | +97.2% | +129.1% | +104.6% | +88.1% | +60.4% | +79.8% | +3.7% | -1079.5% | -932.0% | -3272.4% | -417.4% | -43.9% | -123.5% | -94.7% | -165.6% | +21.4% | +52.0% | +243.5% | +62.8% | |
| ROA | -1.9% | 1.4% | -0.0% | 0.2% | 0.1% | -0.5% | -0.7% | -0.8% | -2.8% | -5.1% | -2.0% | -4.9% | -3.6% | 0.6% | -0.2% | 0.2% | -0.7% | 1.1% | 1.0% | 3.1% | 1.0% |
| — | +367.7% | +97.3% | +127.2% | +104.1% | +89.9% | +66.9% | +83.5% | +21.4% | -934.5% | -814.9% | -3046.9% | -390.3% | -46.6% | -122.6% | -94.7% | -170.7% | +29.6% | +58.2% | +240.1% | +53.3% | |
| ROIC | 3.0% | 0.6% | 0.8% | 0.8% | 0.9% | 0.7% | 0.7% | 0.6% | 1.1% | -0.1% | 0.6% | 0.7% | -1.0% | — | 1.2% | 1.3% | 1.4% | 1.3% | 1.4% | 1.4% | 1.5% |
| — | -3.1% | +5.8% | +24.4% | -13.9% | +730.6% | +22.3% | -11.6% | +207.8% | — | -48.9% | -45.3% | -171.1% | — | -16.9% | -12.9% | -5.9% | -11.7% | -1.7% | -2.8% | +1.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.13 | 2.00 | 2.16 | 2.15 | 2.13 | 2.09 | 2.03 | 2.02 | 1.86 | 1.72 | 1.54 | 1.53 | 1.34 | 1.23 | 1.23 | 1.24 | 1.21 | 1.07 | 1.14 | 1.13 | 1.35 |
| — | -4.4% | +6.4% | +6.4% | +14.8% | +21.9% | +31.7% | +31.9% | +38.7% | +40.2% | +25.0% | +23.8% | +11.0% | +14.3% | +7.7% | +9.0% | -10.4% | -15.3% | -6.5% | -7.9% | +9.8% | |
| Debt / EBITDA | 12.09 | 49.83 | 45.50 | 45.73 | 41.15 | 50.52 | 47.84 | 54.72 | 34.11 | 50.33 | 42.32 | 43.71 | — | 32.32 | 15.58 | 26.07 | 24.56 | 23.52 | 22.92 | 22.19 | 24.85 |
| — | -1.4% | -4.9% | -16.4% | +20.7% | +0.4% | +13.1% | +25.2% | — | +55.8% | +171.7% | +67.6% | — | +37.4% | -32.0% | +17.5% | -1.2% | -1.6% | -5.3% | -9.7% | +3.1% | |
| Current Ratio | 1.51 | 1.49 | 0.31 | 11.12 | 1.51 | 1.43 | 1.41 | 1.41 | 1.55 | 1.37 | 1.56 | 0.70 | 1.61 | 3.82 | 3.27 | 3.70 | — | 5.80 | 5.96 | 5.22 | 7.49 |
| — | +4.4% | -78.2% | +687.0% | -3.1% | +3.9% | -9.5% | +102.1% | -3.7% | -64.1% | -52.3% | -81.1% | — | -34.0% | -45.1% | -29.2% | — | -40.9% | -21.4% | -52.4% | -18.6% | |
| Quick Ratio | 1.51 | 1.49 | 0.31 | 11.12 | 1.51 | 1.43 | 1.41 | 1.41 | 1.55 | 1.37 | 1.56 | 0.70 | 1.61 | 3.82 | 3.27 | 3.70 | — | 5.80 | 5.96 | 5.22 | 7.49 |
| — | +4.4% | -78.2% | +687.0% | -3.1% | +3.9% | -9.5% | +102.1% | -3.7% | -64.1% | -52.3% | -81.1% | — | -34.0% | -45.1% | -29.2% | — | -40.9% | -21.4% | -52.4% | -18.6% | |
| Interest Coverage | 0.53 | 2.39 | 1.07 | 1.00 | 3.21 | 0.27 | 0.32 | 0.06 | 0.61 | -6.45 | -2.01 | -6.95 | -1.96 | 2.19 | -0.72 | 2.34 | 2.78 | 2.68 | 3.09 | 3.09 | 2.40 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MPT stock.
Medical Properties Trust, Inc.'s current P/E is 4.3x. The average P/E over the last 3 quarters is 22.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Medical Properties Trust, Inc.'s current operating margin is 55.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Medical Properties Trust, Inc.'s business trajectory between earnings reports.